🇺🇸 FDA

Company profile · Sponsor

Xijing

Xijing Hospital

CA9927B · NMPA pharma CN
Pipeline
4
Drugs
0
Patents
0

Quick answer

Xijing (CA9927B) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CA9927B
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (4)

Search pipeline →

  1. BCMA/CD19 Dual-Target CAR-T

    Xijing

    Multiple Myeloma

    phase 1 mab active

    1 trial

  2. 18F-P3BZA

    Xijing

    Melanoma

    other active

    1 trial

  3. Folic Acid

    Xijing

    Stroke

    small molecule terminated

    1 trial

  4. Intraoperative identification method

    Xijing

    Thyroid Cancer

    other active

    1 trial

Frequently asked questions

What is Xijing?

Xijing (CA9927B) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Xijing sponsor?

We track 4 ClinicalTrials.gov-linked programs for Xijing, including BCMA/CD19 Dual-Target CAR-T and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Xijing company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.